German court suspends mRNA patent trial against BioNTech Business, Therapeutics The Duesseldorf regional court said it needed further clarification and suspended the case, brought by BioNTech competitor CureVac, pending a decision by the federal patent court on a lawsuit filed by BioNTech. Read more September 28, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/05/ReutersCOVID-19drop5-6-2022.webp 727 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-09-28 04:51:562023-09-28 10:07:10German court suspends mRNA patent trial against BioNTech
